Cleveland Clinic Journal of Medicine

  • Minocycline-induced hyperpigmentation
    Mahmoud Abdelghany, MD and Alan J. Kivitz, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 876-877; DOI: https://doi.org/10.3949/ccjm.83a.16058

    The patient presented with extensive bluish skin discoloration that had started 1 year earlier as a small area and then spread.

  • What stool testing is appropriate when diarrhea develops in a hospitalized patient?
    Sheena K. Ramdeen, MD, MPH and Glenn W. Wortmann, MD, FIDSA, FACP
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 882-884; DOI: https://doi.org/10.3949/ccjm.83a.16039

    Most cases are not due to infection, but Clostridium difficile is the most common infectious cause.

  • When should an indwelling pleural catheter be considered for malignant pleural effusion?
    Abdul Hamid Alraiyes, MD, FCCP, Kassem Harris, MD, FCCP and Thomas R. Gildea, MD, MS, FCCP
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 891-894; DOI: https://doi.org/10.3949/ccjm.83a.15075

    Consider catheter placement if symptoms and effusions recur or if pleurodesis fails.

  • Taurine, energy drinks, and neuroendocrine effects
    Jonathan J. Caine, MD and Thomas D. Geracioti, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 895-904; DOI: https://doi.org/10.3949/ccjm.83a.15050

    Taurine is a major ingredient in popular energy drinks, but little is known about its neuroendocrine effects.

  • Women’s health 2016: An update for internists
    Pelin Batur, MD, NCMP, CCD, Eleanor Bimla Schwarz, MD, MS, Judith M. E. Walsh, MD, MPH and Kay M. Johnson, MD, MPH
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 905-913; DOI: https://doi.org/10.3949/ccjm.83a.16098

    Important studies of urinary tract infections, bisphosphonates, ovarian cancer screening, and contraception.

  • Radiation-induced heart disease: A practical guide to diagnosis and management
    Eoin Donnellan, MD, Dermot Phelan, MD, PhD, Cian P. McCarthy, MD, Patrick Collier, MD, PhD, Milind Desai, MD and Brian Griffin, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 914-922; DOI: https://doi.org/10.3949/ccjm.83a.15104

    Unfortunately, radiotherapy for breast cancer or lymphoma can damage the heart.

  • Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
    Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
    Ali Ataya, MD, Jessica Cope, PharmD, Abbas Shahmohammadi, MD and Hassan Alnuaimat, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 923-932; DOI: https://doi.org/10.3949/ccjm.83a.15116

    The risk of hemorrhage is signifi cant, and the benefi t is unclear. A one-treatment-for-all approach cannot be applied.

  • Thrombolysis in submassive pulmonary embolism: Finding the balance
    Carlos L. Alviar, MD and Gustavo A. Heresi, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 933-936; DOI: https://doi.org/10.3949/ccjm.83a.16099

    In massive pulmonary embolism, thrombolytic therapy is usually indicated; in submassive cases the decision is not so clear.

  • The peacock and the doctor
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 776-777; DOI: https://doi.org/10.3949/ccjm.83b.11016

    Of the seven deadly sins, the worst is pride—avoid a chauvinistic attitude when caring for international patients.

  • In reply: Menopausal hormone therapy (August 2016)
    Laura Dorr Lipold, MD, Pelin Batur, MD, NCMP, CCD and Risa Kagan, MD, FACOG, CCD, NCMP
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 778-785; DOI: https://doi.org/10.3949/ccjm.83c.11002

Pages